T78335
Inetetamab
TargetMol
DESCRIPTION
Inetetamab, a monoclonal antibody, targets domain IV of the HER2 receptor and demonstrates antitumor activities both as a standalone therapy and when combined with tyrosine kinase inhibitors [1] [2].
DETAILS
- Purity: 98%
- Category: Compound
Lead Time: 4 - 5 weeks
Sign in to view pricing